Richard Newitter
Stock Analyst at Truist Financial
(4.19)
# 1,528
Out of 5,073 analysts
1041
Total ratings
47.7%
Success rate
5.6%
Average return
Main Sectors:
Stocks Rated by Richard Newitter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BSX Boston Scientific | Reiterated: Buy | $51 | $44.51 | +14.58% | 55 | Oct 14, 2026 | |
| INSP Inspire Medical Systems | Reiterated: Hold | $62 → $78 | $71.07 | +9.75% | 68 | Oct 14, 2026 | |
| SIBN SI-BONE | Reiterated: Buy | $23 → $25 | $20.82 | +20.08% | 18 | Oct 14, 2026 | |
| TFX Teleflex | Reiterated: Hold | $142 | $130.40 | +8.90% | 66 | Oct 14, 2026 | |
| VCEL Vericel | Reiterated: Buy | $52 | $40.94 | +27.02% | 21 | Oct 14, 2026 | |
| SYK Stryker | Reiterated: Hold | $340 → $310 | $297.60 | +4.17% | 50 | Oct 6, 2026 | |
| CARL Carlsmed | Reiterated: Buy | n/a | $14.31 | - | 9 | Sep 29, 2026 | |
| BBNX Beta Bionics | Rated: Buy | $23 → $28 | $18.37 | +52.42% | 16 | Sep 24, 2026 | |
| MMED MiniMed Group | Initiated Coverage: Buy | $29 | $17.80 | +62.92% | 1 | Sep 24, 2026 | |
| TNDM Tandem Diabetes Care | Rated: Buy | $31 → $28 | $16.34 | +71.36% | 10 | Sep 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $102 | $80.26 | +27.09% | 13 | Sep 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $106 | $94.86 | +11.74% | 73 | Sep 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $86 → $99 | $93.03 | +6.42% | 49 | Sep 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $113.55 | - | 35 | Aug 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4 → $5 | $4.14 | +20.77% | 37 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 | $78.68 | +27.10% | 56 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $210 → $153 | $141.90 | +7.82% | 16 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $21 | $18.27 | +14.94% | 42 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $110 → $127 | $126.70 | +0.24% | 19 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $125 → $103 | $100.24 | +2.25% | 60 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $180 → $215 | $176.85 | +21.57% | 24 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $95 | $88.40 | +7.47% | 41 | Jul 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $580 → $510 | $428.12 | +19.13% | 73 | Jul 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $20 | $23.84 | -16.11% | 17 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $53.93 | - | 1 | Jan 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $370 → $374 | $323.56 | +15.59% | 27 | Jan 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $13 | $11.84 | +9.80% | 33 | Dec 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $112.63 | n/a | 1 | Jun 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $28.78 | n/a | 1 | Jun 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $211.97 | n/a | 1 | Oct 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $11.18 | n/a | 1 | Jun 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $28.44 | n/a | 1 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $148 | $174.74 | n/a | 1 | Aug 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.9913 | n/a | 10 | Oct 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $20 | $4.90 | n/a | 3 | Sep 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | CHF 59.08 → CHF 66.45 | CHF 55.92 | n/a | 11 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $177.75 | n/a | 4 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 | $36.48 | n/a | 13 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $260 → $250 | $194.34 | n/a | 16 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $5.69 | n/a | 3 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $770 | $151.37 | n/a | 26 | Jul 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $141 | $47.11 | n/a | 14 | Jul 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $45 | $100.51 | n/a | 1 | Jul 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $57.67 | n/a | 1 | Jul 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $47 | $24.70 | n/a | 1 | Jul 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $140 | $257.78 | n/a | 1 | Jul 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $4.5 | $7.97 | n/a | 1 | Jul 15, 2016 |
Boston Scientific
Oct 14, 2026
Reiterated: Buy
Price Target: $51
Current: $44.51
Upside: +14.58%
Inspire Medical Systems
Oct 14, 2026
Reiterated: Hold
Price Target: $62 → $78
Current: $71.07
Upside: +9.75%
SI-BONE
Oct 14, 2026
Reiterated: Buy
Price Target: $23 → $25
Current: $20.82
Upside: +20.08%
Teleflex
Oct 14, 2026
Reiterated: Hold
Price Target: $142
Current: $130.40
Upside: +8.90%
Vericel
Oct 14, 2026
Reiterated: Buy
Price Target: $52
Current: $40.94
Upside: +27.02%
Stryker
Oct 6, 2026
Reiterated: Hold
Price Target: $340 → $310
Current: $297.60
Upside: +4.17%
Carlsmed
Sep 29, 2026
Reiterated: Buy
Price Target: n/a
Current: $14.31
Upside: -
Beta Bionics
Sep 24, 2026
Rated: Buy
Price Target: $23 → $28
Current: $18.37
Upside: +52.42%
MiniMed Group
Sep 24, 2026
Initiated Coverage: Buy
Price Target: $29
Current: $17.80
Upside: +62.92%
Tandem Diabetes Care
Sep 24, 2026
Rated: Buy
Price Target: $31 → $28
Current: $16.34
Upside: +71.36%
Sep 23, 2026
Reiterated: Buy
Price Target: $102
Current: $80.26
Upside: +27.09%
Sep 16, 2026
Reiterated: Hold
Price Target: $106
Current: $94.86
Upside: +11.74%
Sep 2, 2026
Reiterated: Hold
Price Target: $86 → $99
Current: $93.03
Upside: +6.42%
Aug 19, 2026
Reiterated: Buy
Price Target: n/a
Current: $113.55
Upside: -
Aug 10, 2026
Reiterated: Hold
Price Target: $4 → $5
Current: $4.14
Upside: +20.77%
Aug 7, 2026
Reiterated: Buy
Price Target: $100
Current: $78.68
Upside: +27.10%
Aug 6, 2026
Downgraded: Hold
Price Target: $210 → $153
Current: $141.90
Upside: +7.82%
Aug 5, 2026
Reiterated: Hold
Price Target: $21
Current: $18.27
Upside: +14.94%
Aug 4, 2026
Downgraded: Hold
Price Target: $110 → $127
Current: $126.70
Upside: +0.24%
Aug 4, 2026
Downgraded: Hold
Price Target: $125 → $103
Current: $100.24
Upside: +2.25%
Jul 30, 2026
Reiterated: Buy
Price Target: $180 → $215
Current: $176.85
Upside: +21.57%
Jul 24, 2026
Reiterated: Hold
Price Target: $95
Current: $88.40
Upside: +7.47%
Jul 17, 2026
Reiterated: Buy
Price Target: $580 → $510
Current: $428.12
Upside: +19.13%
Mar 2, 2026
Reiterated: Hold
Price Target: $20
Current: $23.84
Upside: -16.11%
Jan 16, 2026
Reiterated: Buy
Price Target: n/a
Current: $53.93
Upside: -
Jan 16, 2026
Downgraded: Hold
Price Target: $370 → $374
Current: $323.56
Upside: +15.59%
Dec 23, 2025
Reiterated: Hold
Price Target: $13
Current: $11.84
Upside: +9.80%
Jun 26, 2025
Reiterated: Buy
Price Target: n/a
Current: $112.63
Upside: n/a
Jun 18, 2025
Reiterated: Buy
Price Target: n/a
Current: $28.78
Upside: n/a
Oct 16, 2024
Rated: Buy
Price Target: n/a
Current: $211.97
Upside: n/a
Jun 20, 2024
Rated: Buy
Price Target: n/a
Current: $11.18
Upside: n/a
Apr 17, 2024
Reiterated: Buy
Price Target: n/a
Current: $28.44
Upside: n/a
Aug 22, 2023
Reiterated: Hold
Price Target: $148
Current: $174.74
Upside: n/a
Oct 7, 2021
Reiterated: Buy
Price Target: n/a
Current: $0.9913
Upside: n/a
Sep 10, 2021
Initiated Coverage: Buy
Price Target: $20
Current: $4.90
Upside: n/a
Aug 17, 2021
Reiterated: Hold
Price Target: CHF 59.08 → CHF 66.45
Current: CHF 55.92
Upside: n/a
Aug 6, 2021
Rated: Buy
Price Target: n/a
Current: $177.75
Upside: n/a
Aug 5, 2021
Reiterated: Buy
Price Target: $27
Current: $36.48
Upside: n/a
Aug 5, 2021
Rated: Hold
Price Target: $260 → $250
Current: $194.34
Upside: n/a
Aug 5, 2021
Reiterated: Buy
Price Target: $20
Current: $5.69
Upside: n/a
Jul 28, 2021
Rated: Buy
Price Target: $770
Current: $151.37
Upside: n/a
Jul 28, 2021
Rated: Hold
Price Target: $141
Current: $47.11
Upside: n/a
Jul 15, 2016
Rated: Hold
Price Target: $45
Current: $100.51
Upside: n/a
Jul 15, 2016
Reiterated: Buy
Price Target: $20
Current: $57.67
Upside: n/a
Jul 15, 2016
Rated: Hold
Price Target: $47
Current: $24.70
Upside: n/a
Jul 15, 2016
Rated: Buy
Price Target: $140
Current: $257.78
Upside: n/a
Jul 15, 2016
Rated: Buy
Price Target: $4.5
Current: $7.97
Upside: n/a